CRESSKILL, N.J., Feb. 1, 2013 /PRNewswire/ -- Alquemiste LLC, a leading provider of patented homeopathic remedies, has launched a product to address achy joints, muscle discomfort and inflammatory pain without narcotics, steroids, smelly ointments or skin-irritating ingredients.
PRIME Therapy is an all-natural topical pain reliever that reduces swelling and inflammation in joints and muscles in a short amount of time. Medical doctors, chiropractors and physical therapists recommend it to treat common pain conditions ranging from arthritis to carpal tunnel syndrome, and plantar fasciitis to sports strains, such as tennis elbow.
More Americans are affected by pain than diabetes, heart disease and cancer combined, according to the American Academy of Pain Medicine. "Muscle and joint inflammation can be incredibly painful," says Robert Kramer, vice president of marketing for Ateevia. "On a chronic level, it can cause significant physiological damage to the human body. Ateevia's PRIME is a daily defense cream against pain. It has the ability to shift the approach to inflammatory pain relief because the product is so safe; people tend to use it preventatively."PRIME represents years of research and development by an anesthesiologist. Based upon his grandfather's formula, this physician refined the treatment to make it safer, stronger, and more effective. The cream contains a blend of organic ingredients with anti-inflammatory properties: pumpkin seed and sunflower seed extract, along with borage, poke root and safflower oil. The natural phytonutrient power of the ingredients is enhanced by Ateevia's manufacturing process. PRIME does not contain capsaicin, a common ingredient in many pain-relieving ointments that can irritate the skin. It does not interfere with other medications. It is applied 2-3 times a day (more if the pain is chronic), by massaging a nickel-sized amount into the skin until completely absorbed. The cream is already proving to be clinically effective. An independent university study found the therapy helped decrease pain and improve mobility in chronic pain sufferers within the first week of use. Additionally, more than 85 percent of patients experienced significant relief within 4 weeks.